Escitalopram Significantly Improves Quality Of Life In Major Depressive Disorder And Generalised Anxiety Disorder

Treatment with the selective serotonin reuptake inhibitor escitalopram significantly improves quality of life in patients with major depressive disorder (MDD) or generalised anxiety disorder (GAD), according to a meta-analysis reported this week at the European College of Neuropsychopharmacology Congress (13-17 October, Vienna, Austria). [click link for full article]

More: continued here

Filed under: Anxiety on October 25th, 2007